Medications not yet evaluated by P&T are considered NON-FORMULARY . . . . . Always check 2 unique patient identifiers - NAME and DATE OF BIRTH - at every step! . . . . . Please be sure to document all clinical activities daily.
Search results for:

tadalafil

tadalafil
  • Restricted Adcirca --> Restricted to initiation by pulmonology, cardiology, pediatric critical care, and rheumatology.
  • Restricted Cialis --> Restricted to the treatment of BPH.
  • Restricted Miscellaneous Program Formulary
Drug Name Form Strength Formulary Unrestricted Formulary Restricted Non-Formulary Interchange
Cialis TABLET, ORAL 5 mg      
Cialis TABLET, ORAL 10 mg, 20 mg      
Adcirca TABLET, ORAL 20 mg      
VIEW MORE Phosphodiesterase Type 5 Inhibitors
CLASS
240812
Comments:

Adcirca is approved for sample use in HH Endocrinology and Diabetes Clinics.

Adcirca is classified as FORMULARY, restricted to pulmonology, cardiology, rheumatology, and pediatric critical care. Initiation should be deferred to outpatient therapy if possible. Reviewed: September 22, 2009.

Cialis 5 mg is classified as formulary, restricted to use in BPH. Updated: September 23, 2014

Cialis Reviewed: December 15, 2005

Last updated: Apr. 15, 2024






This site is intended for the staff of Huntsville Hospital.
While others may view accessible pages, Huntsville Hospital makes no warranty, express or implied,
as to the use of this information outside of Huntsville Hospital.
Please note than many documents are accessible via the provided link
only when connected to the Huntsville Hospital intranet.

Copyright © 2024 Rpharmy, LLC ­ All Rights Reserved